House Bill 10-69, a measure to regulate vapor products and require manufacturer certification tied to FDA review or approval, was under consideration Feb. 7 but was not finally acted on. Representative Mulder described the bill as a consumer-protection measure that would require manufacturers to certify FDA approval or an FDA application and to disclose ingredients, allow inspections, and show products do not contain harmful constituents. Representative Heinemann offered amendment 10-69A to remove a $100 licensing fee; sponsor called the amendment friendly.

Representative Malawi invoked Joint Rule 5-17, which requires the support of one-fifth of the members to delay immediate action. The invocation was supported and the chair announced a delay: action on the bill with the proposed amendment will be taken up the next legislative day. The clerk and sponsors recorded that the amendment had been distributed and that the body would proceed to other business; no final vote occurred that day.

Action status: HB 10-69 was taken up and an amendment introduced but was delayed under JR 5-17; final consideration was postponed to the next legislative day.